Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.
This study is currently recruiting participants.
Verified by University Hospital, Clermont-Ferrand, November 2007
Sponsors and Collaborators: University Hospital, Clermont-Ferrand
Moulins Hospital
Centre Hospitalier Universitaire de Saint Etienne
LA ROCHE SUR YON HOSPITAL
Information provided by: University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier: NCT00336687
  Purpose

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.


Condition
Thrombopenia

U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.

Further study details as provided by University Hospital, Clermont-Ferrand:

Primary Outcome Measures:
  • Epidemiology of Thrombopenia and its consequences.

Secondary Outcome Measures:
  • The impact of cost and mortality of Thrombopenia in reanimation.

Estimated Enrollment: 322
Study Start Date: July 2005
Estimated Study Completion Date: July 2007
Detailed Description:

About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Study Population

Patients of Reanimation

Criteria

Inclusion Criteria:

  • Thrombopenia in reanimation

Exclusion Criteria:

  • Pregnancy
  • Contraindication of myelogram
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00336687

Contacts
Contact: Fabrice Thiolliere, Dr (33) 04 73 75 19 95

Locations
France, Auvergne
Clermont-Ferrand University Hospital Recruiting
Clermont-Ferrand, Auvergne, France, 63000
Contact: Fabrice Thiolliere, Doctor     (33) 04 73 75 19 95        
Sponsors and Collaborators
University Hospital, Clermont-Ferrand
Moulins Hospital
Centre Hospitalier Universitaire de Saint Etienne
LA ROCHE SUR YON HOSPITAL
Investigators
Study Director: Fabrice Thiolliere, Dr University Hospital, Clermont-Ferrand
  More Information

Study ID Numbers: CHU63-0013
Study First Received: June 13, 2006
Last Updated: November 12, 2007
ClinicalTrials.gov Identifier: NCT00336687  
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Clermont-Ferrand:
Thrombopenia
Reanimation
Thrombopenia in reanimation

Study placed in the following topic categories:
Thrombocytopathy
Thrombocytopenia
Hematologic Diseases
Blood Platelet Disorders

ClinicalTrials.gov processed this record on January 16, 2009